Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 851–900 of 34667
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
On May 13, 2026, the Board was enlarged, Richard H. Coats was appointed as chairman of the Board, and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed and Michael Wallace were appointed as members of the Board.
Effective as of May 14, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Gary Julien, Emily Kreps, and Sheryl Schwartz.
Effective as of May 14, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Gary Julien, Emily Kreps, and Sheryl Schwartz.
Effective as of May 14, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Gary Julien, Emily Kreps, and Sheryl Schwartz.
Jeff Ervin and Jay Roberts, will not seek re-election when their respective terms expire at the Company’s 2026 Annual Meeting of Stockholders
Jeff Hargroves has agreed to resign from the Board as a Class I director solely for the purpose of being re-appointed to the Board as a Class II director.
Jeff Ervin and Jay Roberts, will not seek re-election when their respective terms expire at the Company’s 2026 Annual Meeting of Stockholders
appointed Robert J. Lipstein to fill a vacancy on the Board, effective immediately.
On May 19, 2026, the Company issued a press release announcing Mr. Jhawar’s appointment to and Doug Rauch’s retirement from the Board.
On May 19, 2026, Sprouts Farmers Market, Inc. (the “Company”) announced the appointment of Andrew Jhawar to its Board of Directors (the “Board”) as a Class III director with a term expiring at the Company’s 2028 annual meeting of stockholders.
the Board appointed Andrea Brimmer to serve on the Board, effective May 15, 2026
Also, on May 19, 2026, the Corporation's Board of Directors appointed Paul Fultz to fill the vacancy on the Board created by Mr. Lehman's retirement.
On May 19, 2026, First Merchants Corporation (the “Corporation”) announced the retirement of Gary Lehman from the Board of Directors effective immediately.
On May 19, 2026, A. Lee Finley resigned from his position as a member of the Board of Directors of GBank Financial Holdings Inc. effective immediately.
On May 18, 2026, Zhe Zhang, a member of the Board of Directors (the “Board”) and the audit committee of Valuence Merger Corp. I (the “Company”), resigned from the Board, effective immediately.
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
Joshua Farran was appointed to the Board, effective as of the Effective Time.
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
each of John Danhakl, J. Kristofer Galashan, Ronald Kirk, John Lai, Dovin Lively, Atif Rafiq, Veronica Rogers, Jeffrey Suer and Jodi Taylor resigned from the Company’s board of directors
On May 19, 2026, the board of directors (the “Board”) of Rogers Corporation (the “Company”) appointed Ali El-Haj, currently the Company’s Interim President and Chief Executive Officer, to the positions of President and Chief Executive Officer and as a member of the Board, effective immediately.
On May 19, 2026, Upstart Holdings, Inc. (“Upstart” or the “Company”) announced that its Board of Directors (the “Board”) elected Tim Wennes to serve as a Class I director on the Board, effective as of May 28, 2026.
On May 19 , 2026, Jeff Huber informed the Company that he will resign from the Board and the Nominating and Corporate Governance Committee of the Board, effective as of May 28, 2026.
On May 18, 2026, Robert E. James, Jr. retired as a director of HomeTrust Bancshares, Inc. (the "Company"), the holding company for HomeTrust Bank (the "Bank"), effective at the completion of the Company's annual meeting of stockholders held that day (the "Annual Meeting").
On May 18, 2026, Diego Miralles, M.D. resigned as a member of the Board of Directors (the “Board”) of Artiva Biotherapeutics, Inc. (the “Company”), effective May 18, 2026
Simona Skerjanec, who has been serving as Interim Chairperson since February 2026, will transition from Interim Chairperson and continue to serve as a member of the Board.
On March 18, 2026, Steve Chen resigned as a director of SolarMax Technology, Inc. (the “Company”) for reasons of health.
On May 13, 2026, in connection with the IPO, Jonathan Cole, Jody Sitkoski, and Susie Kuan (together with Gus Garcia, Lewis Silberman and Anantha Ramamurti, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 13, 2026, in connection with the IPO, Jonathan Cole, Jody Sitkoski, and Susie Kuan (together with Gus Garcia, Lewis Silberman and Anantha Ramamurti, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 13, 2026, in connection with the IPO, Jonathan Cole, Jody Sitkoski, and Susie Kuan (together with Gus Garcia, Lewis Silberman and Anantha Ramamurti, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 14, 2026, in connection with the IPO, Eyal Waldman, David DeWalt and Paul Hodermarsky (the “ New Directors ” and, collectively with Tom Y. Livne and Matthew J. Norden, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 14, 2026, in connection with the IPO, Eyal Waldman, David DeWalt and Paul Hodermarsky (the “ New Directors ” and, collectively with Tom Y. Livne and Matthew J. Norden, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 14, 2026, in connection with the IPO, Eyal Waldman, David DeWalt and Paul Hodermarsky (the “ New Directors ” and, collectively with Tom Y. Livne and Matthew J. Norden, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 18, 2026, Scott Cundy was appointed to serve as a director of the Board, effective July 3, 2026, to fill the vacancy resulting from Mr. Wall’s departure.
On May 17, 2026, Brett Wall, a class II director of the Board of Directors (the “Board”) of MiniMed Group, Inc. (“MiniMed”) and member of the Board’s Nominating and Corporate Governance Committee, notified the Board that he will resign from the Board effective July 3, 2026.
On May 12, 2026, in connection with the IPO, James Barresi, Robert Jones, Michael Taff and Joseph V. Topper, Jr. (collectively with Thomas Cestare and Jack Kopnisky, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 12, 2026, in connection with the IPO, James Barresi, Robert Jones, Michael Taff and Joseph V. Topper, Jr. (collectively with Thomas Cestare and Jack Kopnisky, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 12, 2026, in connection with the IPO, James Barresi, Robert Jones, Michael Taff and Joseph V. Topper, Jr. (collectively with Thomas Cestare and Jack Kopnisky, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 12, 2026, in connection with the IPO, James Barresi, Robert Jones, Michael Taff and Joseph V. Topper, Jr. (collectively with Thomas Cestare and Jack Kopnisky, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On May 13, 2026, the Board of Directors (the “Board”) of 60 Degrees Pharmaceuticals, Inc. (the “Company”) appointed Eric Francois to serve as a member of the Board, effective immediately.
On May 15, 2026, the Board of Directors (the “Board”) of Ashland Inc. (the “Company”) increased the size of the Board from eight to nine directors and appointed Mr. Bertrand Loy to serve as an independent director on the Board, effective the same day.
On May 18, 2026, the board of directors (the “Board”) of Penguin Solutions, Inc. (the “Company”) increased the authorized size of the Board to eight members, and upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed David Heard to the Board and as a member of the Compensation Committee of the Board, effective immediately.
On May 12, 2026, Derek Small and Mark DiPaolo Esq. tendered their resignations from the Board of Directors of Innoviva, Inc.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.